Get involvedDonate today
Donate today
Donate today
September 13, 2023, 12:00pm – 1:00pm EDT

Rare Disease Spotlight: Immune-related kidney diseases

In this webinar, we'll discuss a group of rare kidney diseases that are connected to the immune system, your body's cells and tissues that fight infection.

Our guest speaker, nephrologist Laura H. Mariani, MD MSCE will provide an overview of these rare diseases, using one particular type of disease called complement 3 glomerulopathy or C3G as an example. Other types of rare kidney diseases related to the immune system are IgA nephropathy (IgAN), atypical hemolytic uremic syndrome (aHUS) and membranous nephropathy (MN). In this webinar, you'll learn more about the causes of these types of diseases, how they are diagnosed and steps you or your loved one can take to slow down any damage to kidneys that may be caused by these rare kidney diseases.   

Join the conversation to: 

  • Learn more about rare kidney diseases related to your immune system, how they are diagnosed and how they are managed 

  • Find out what to ask your health care team about C3G and other rare kidney diseases related to your immune system

Educational content supported by Novartis

Speaker

Dr. Laura Mariani, MD MSCE

Dr. Laura Mariani, MD MSCE

Laura H. Mariani, MD, MS, is a nephrologist and clinical researcher at the University of Michigan Division of Nephrology. She completed her medical school training at the University of Michigan and subsequently completed her internal medicine residency, chief residency, nephrology fellowship, and Masters of Science in Clinical Epidemiology at the University of Pennsylvania.  

Dr. Mariani is currently an Associate Professor in the Division of Nephrology at the University of Michigan. She has a primary clinical and research interest in observational studies in glomerular disease. She is involved in several clinical and translational NIH-funded research studies in kidney diseases, including the Nephrotic Syndrome Study Network (NEPTUNE), the Cure Glomerulonephropathy (CureGN) Consortium, and the Kidney Precision Medicine Program (KPMP) Central Hub. 

Additionally, Dr. Mariani's primary research interest is in developing and applying statistical methods for clinical outcome definition and prediction of kidney disease progression as well as linking clinical phenotype to novel biomarkers and high dimensional omics data to better understand disease mechanisms that can be targeted for therapy in glomerular disease.